Format

Send to

Choose Destination
Leukemia. 2018 Oct;32(10):2278-2281. doi: 10.1038/s41375-018-0059-3. Epub 2018 Feb 20.

Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia.

Author information

1
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
2
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. zestrov@mdanderson.org.
PMID:
29479067
DOI:
10.1038/s41375-018-0059-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center